Dr. Isaac Bright joined Imagion Biosystems as Chief Executive Officer in June 2023. Before entering Imagion, Dr. Bright served as Co-Founder, CEO, and Chairman of RubrYc Therapeutics, Inc. before its trade sale to iBio, Inc. (NYSEA: IBIO) in September 2022. Prior to launching RubrYc, Dr. Bright was Chief Business Officer for molecular diagnostics innovator HealthTell, […]
